Stay updated on Pembrolizumab Maintenance Post-Chemo in Metastatic Bladder Ca Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Maintenance Post-Chemo in Metastatic Bladder Ca Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Maintenance Post-Chemo in Metastatic Bladder Ca Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage, indicating a shift in the dosage or frequency of the investigational treatment being studied in the clinical trial for maintenance pembrolizumab versus placebo after first-line chemotherapy in patients with metastatic urothelial cancer.
    Difference
    0.1%
    Check dated 2024-06-06T14:18:46.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The value 'Participation Criteria 6' has been updated to 'Participation Criteria Researchers look for people who fit a certain description, called eligibility criteria.' This change provides a more detailed explanation of eligibility criteria, including examples such as a person's general health condition or prior treatments.
    Difference
    36%
    Check dated 2024-05-22T20:55:12.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Summary
    The value 'Go to the classic website' has been updated to 'Site Map' on the webpage, indicating a change in the type of intervention being discussed, possibly related to medical and healthcare publications and documentation.
    Difference
    0.8%
    Check dated 2024-05-01T18:40:47.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Maintenance Post-Chemo in Metastatic Bladder Ca Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Maintenance Post-Chemo in Metastatic Bladder Ca Clinical Trial page.